LAS VEGAS, Aug. 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson, will be interviewed on the NBC Las Vegas affiliate KVBC Channel 3. “News 3 at Sunrise” will be aired early Sunday morning, August 26, from 6 AM to 7AM. Dr. Greeson will be showing videos to explain the “mechanism of action” and the drug’s substantial benefit over what is currently on the market for Samaritan’s Alzheimer’s drug SP-233, its late stage HIV drug resistance drug SP-01A and Samaritan’s Neuronal Stem Cell therapy for the potential use with Alzheimer’s disease, Spinal Cord injury and Stroke.
